Catalog Number 1500400-38 |
Device Problems
Difficult to Remove (1528); Material Rupture (1546); Difficult or Delayed Activation (2577); Patient-Device Incompatibility (2682)
|
Patient Problems
Arrhythmia (1721); Bradycardia (1751); Cardiac Arrest (1762); Myocardial Infarction (1969); Occlusion (1984); Respiratory Failure (2484)
|
Event Date 07/31/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
The stent remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.User facility medwatch report number (b)(4).
|
|
Event Description
|
User facility medwatch report received that states: "stent delivery balloon ruptured during inflation after approx 6-8 atmospheres of pressure; (b)(6) 2020 procedure - the intervention was complicated by technical malfunction of the 4.0 x 38 mm xience stent in the mid right coronary artery.The stent delivery balloon ruptured during inflation after approximately 6 to 8 atmospheres of pressure.This resulted in incomplete expansion of the stent.We were unable to remove the stent delivery balloon or get the device out through the guide catheter.Ultimately, it was further partially and asymmetrically deployed, as detailed below, using the ruptured balloon.With this complication, the patient developed bradycardiac cardia arrest, essentially with the transient asystole and subsequent severe bradycardia.Ultimately, she would require iv vasopressor and inotropic therapy, as wall as emergent intubation for airway support.Intubation was provided by the emergency room physician and subsequent airway management and vasopressor therapy guided by the critical care staff.With this complication, we also lost flow through the right coronary artery.Ultimately we were able to restore flow through the artery, but the patient did suffer an infraction as a result.".
|
|
Manufacturer Narrative
|
The device was not returned for analysis.A review of the lot history record and complaint history of the reported lot could not be conducted because the lot number was not provided.The reported patient effects arrhythmia, occlusion, and myocardial infarction are listed in the xience sierra everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.The investigation was unable to determine a conclusive cause for the reported material rupture; however, factors that may contribute to material ruptures include, but are not limited to, material damage, interactions with other devices or interaction with lesion calcification and tortuosity.Removal of the delivery catheter was difficult as the device met resistance with the guiding catheter due to the ruptured balloon.The stent was ultimately implanted using the ruptured balloon; however, the reported delayed activation and subsequent issue with wall apposition were experienced.The reported patient effects and treatment appear to be related to operational context of the procedure.It should be noted that the device was not returned for analysis and although multiple attempts were made to attain further information, no information was provided.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
|
Search Alerts/Recalls
|
|